Clinical Trial Update: Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003) [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study in adults with Attention-Deficit/Hyperactivity Disorder completed; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• MK-8777 (unknown)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2 | Status: COMPLETED | Results posted: 2014-08-29